Purpose: Cyclins play a key role in the control and regulation of the cell
cycle. The;role of cyclins in the pathogenesis of pancreatic cancer is larg
ely unknown. Methods: Using Northern blot analysis, polymerase chain reacti
on (PCR) and immunohistochemistry, we examined the expression of cyclins D1
, D2, and D3 in human pancreatic cancer and studied the induction of these
cyclins by growth factors in pancreatic cancer cell lines. Results: We now
report that cyclin D1 and D3 mRNAs are expressed in human pancreatic cancer
cell lines, and that the expression of cyclin D3 is enhanced in pancreatic
cancer cells by amphiregulin, a member of the epidermal growth factor fami
ly. Cyclins D1 and D3 are also expressed in normal and malignant pancreatic
tissues. However, while the normal pancreas and pancreatic cancers express
cyclin D2 as determined by reverse-transcriptase PCR, we could not detect
cyclin D2 mRNA by either Northern blot analysis or reverse transcriptase PC
R in the two pancreatic cancer cell lines. Immunohistochemical analysis rev
ealed the expression of cyclin D3 in pancreatic cancer cells. Conclusions:
These findings suggest that D-type cyclins are differentially expressed in
pancreatic cancer and that the aberrant activation of the EGF receptor in h
uman pancreatic cancer by amphiregulin may lead to the progression of the c
ell cycle via induction of cyclin D3 expression, thus contributing to the g
rowth advantage of these transformed cells.